Examining inequities in access to opioid agonist treatment (OAT) take-home doses (THD): A Canadian OAT guideline synthesis and systematic review
Author:
Funder
Canadian Institutes of Health Research
Publisher
Elsevier BV
Reference116 articles.
1. The impact of relaxing restrictions on take-home doses during the COVID-19 pandemic on program effectiveness and client experiences in opioid agonist treatment: A mixed methods systematic review;Adams;Substance Abuse Treatment, Prevention, and Policy,2023
2. COVID-19 guidance for pharmacists and pharmacy technicians,2020
3. Opioid Agonist Therapy (OAT) guidelines Medication-assisted treatment for opioid use disorder: Guidelines for pharmacists and pharmacy technicians,2022
4. Methadone and buprenorphine-related deaths among people prescribed and not prescribed Opioid Agonist Therapy during the COVID-19 pandemic in England;Aldabergenov;International Journal of Drug policy,2022
5. Changes in methadone take-home dosing before and after COVID-19;Amram;Journal of Substance Abuse Treatment,2022
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3